Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-089323
Filing Date
2025-04-22
Accepted
2025-04-22 17:14:35
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d904220ddefa14a.htm DEFA14A 11451
2 GRAPHIC g904220dsp002.jpg GRAPHIC 287339
3 GRAPHIC g904220dsp003.jpg GRAPHIC 223330
  Complete submission text file 0001193125-25-089323.txt   716263
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Filer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39485 | Film No.: 25858550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)